Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2019-03-11 AGM Information
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the scheduling of a General Meeting of Shareholders. It specifically addresses the 'Concentration Day' (a date where many companies hold meetings) and explains why the company is holding its meeting on a specific date despite the concentration. Since this is a regulatory notification regarding meeting logistics and compliance with exchange rules rather than the meeting materials themselves or voting results, it falls under the general regulatory filing category.
2019-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Gencurix, Inc. It includes the meeting agenda, details on director appointments, and financial statements (balance sheet, income statement, etc.) to be approved at the meeting. This type of document is a standard Proxy Solicitation & Information Statement, which provides shareholders with the necessary information to vote on matters at the upcoming Annual General Meeting.
2019-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-02-18 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 97% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a breast cancer treatment prediction method by Gencurix. It does not fit into financial reporting, governance, or shareholder meeting categories. As it is a specific regulatory announcement regarding company intellectual property that does not fall into the other defined categories, it is classified as a general regulatory filing.
2019-02-15 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 95% confidence The document is a short regulatory disclosure (611 characters) from Gencurix regarding the filing of a preliminary application for KOSDAQ market listing. It is a specific corporate announcement regarding a regulatory process (listing application) rather than a full financial report or a specific category like M&A or dividend notice. As it is a general regulatory announcement that does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS).
2019-01-10 Korean
이전상장결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from a Korean company (Gencurix) announcing a decision to transfer its stock listing to the KOSDAQ market. It details the board resolution, the reasons for the transfer, and the timeline. Since this is a specific regulatory announcement regarding corporate structure and listing status that does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2019-01-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.